LiGalli develops the MedRing, a self-insertable medical device designed to release small doses of medication in the vagina according to a personalized delivery schedule. The company focuses on enhancing the quality of life and care for women by empowering patients and healthcare professionals with intelligent drug delivery and health data solutions. LiGalli aims to provide innovative FemTech solutions that integrate drug delivery and diagnostics to improve women's health outcomes.